Sirtex Medical Presents SIR-Spheres(R) Microspheres Data At The American Brachytherapy Society 2006 Meeting

PHILADELPHIA--(BUSINESS WIRE)--May 9, 2006--New research on Sirtex’s SIR-Spheres® microspheres will be presented at the 2006 American Brachytherapy Society’s annual meeting held May 10-12 in Philadelphia. Dr. Andrew Kennedy, co-medical director of Wake Radiology Oncology Services in Cary, N.C., will discuss findings of two studies involving SIR-Spheres microspheres for treatment of advanced liver cancer. Dr. Kennedy’s presentation marks the first time microspheres therapy has been featured at the ABS meeting. Sirtex’s SIR-Spheres microspheres are the only FDA-approved microspheres therapy for metastatic liver cancer.

MORE ON THIS TOPIC